OmicsPharLeuDB: an integrative database for mining pharmacogenomic data in acute lymphoblastic leukemia
Peng, Y. Z.
Show abstract
Leukemia is one of the most common hematological malignancies in children. Recent cancer pharmacogenomic studies profiled large panels of cell lines against hundreds of approved drugs and experimental chemical compounds. However, until now, no comprehensive databases have been specifically designed for leukemia. Therefore, we have developed OmicsPharLeuDB (mugpeng.shinyapps.io/leu_web_english_peng_v2/), a database that includes the largest published studies investigating the viability response of human leukemia cell lines to chemical compound treatment, and the association between drug sensitivity and multi-omics, and also provides a user-friendly interactive website allowing the user to assess drug sensitivity data from a different platform and find the potential relationship between drugs and omics.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Investigate the relevance of major signaling pathways in cancer survival using a biologically meaningful deep learning model 93%
- Quantitative Structure-Mutation-Activity Relationship Tests (QSMART) Model for Protein Kinase Inhibitor Response Prediction 92%
- RAFTS3G - An efficient and versatile clustering software to analyses in large protein datasets 91%
Similar papers in this journal
- MicroRNA childhood Cancer Catalog (M3Cs): A Resource for Translational Bioinformatics Toward Health Informatics in Pediatric Cancer. 94%
- Integrated ACMG approved genes and ICD codes for the translational research and precision medicine 92%
- SynLethDB 2.0: A web-based knowledge graph database on synthetic lethality for novel anticancer drug discovery 92%
Similar papers in this journal
- Antivirals for Monkeypox Virus: Proposing an Effective Machine/Deep Learning Framework 94%
- An interactive retrieval system for clinical trial studies with context-dependent protocol elements 93%
- Improving prediction of drug-target interactions based on fusing multiple features with data balancing and feature selection techniques 93%
Similar papers in this journal
- Analysis of Mutations in Precision Oncology using The Automated, Accurate, and User-Friendly Web Tool PredictONCO 94%
- Drug repositoning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. 93%
- Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.